Kite Pharma, Inc. Insider Trading for August 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. for August 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Option Exercise | M | 1.35 | 10,000 | 13,500 | 265,394 | |
| Aug 26 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 59.02 | 2,500 | 147,550 | 95,477 | 98 K to 95.5 K (-2.55 %) |
| Aug 26 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Sell | S | 58.03 | 7,500 | 435,225 | 97,977 | 105.5 K to 98 K (-7.11 %) |
| Aug 26 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | Chief Operating Off ... | Buy | M | 1.35 | 10,000 | 13,500 | 105,477 | 95.5 K to 105.5 K (+10.47 %) |
| Aug 16 2016 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | M | 51.43 | 2,400 | 123,432 | 84,100 | |
| Aug 16 2016 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | M | 51.43 | 33,500 | 1,722,905 | 86,500 | |
| Aug 16 2016 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Option Exercise | A | 51.43 | 120,000 | 6,171,600 | 120,000 | |
| Aug 16 2016 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 63.01 | 2,400 | 151,229 | 9,000 | 11.4 K to 9 K (-21.05 %) |
| Aug 16 2016 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Buy | M | 51.43 | 2,400 | 123,432 | 11,400 | 9 K to 11.4 K (+26.67 %) |
| Aug 16 2016 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Sell | S | 60.08 | 33,500 | 2,012,596 | 9,000 | 42.5 K to 9 K (-78.82 %) |
| Aug 16 2016 | KITE | Kite Pharma, Inc. | Kim Helen Susan | EVP, Business Devel ... | Buy | M | 51.43 | 33,500 | 1,722,905 | 42,500 | 9 K to 42.5 K (+372.22 %) |
| Aug 02 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | M | 6.89 | 1,500 | 10,335 | 80,708 | |
| Aug 02 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 57.24 | 609 | 34,859 | 14,867 | 15.5 K to 14.9 K (-3.94 %) |
| Aug 02 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 56.66 | 891 | 50,484 | 15,476 | 16.4 K to 15.5 K (-5.44 %) |
| Aug 02 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Buy | M | 6.89 | 1,500 | 10,335 | 16,367 | 14.9 K to 16.4 K (+10.09 %) |